Senior insider sale
President & CEO at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$6.34M
100K shares
What this filing means
BRYNJELSEN SEAN plans to sell 100K shares of ETON PHARMACEUTICALS, INC. valued at approximately $6.34M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/19/2026ACC: 0001974078-26-000315
DirectorOfficer· President & CEO
Since Nov 2018
100K
Shares to sell
$6.34M
Approx. market value
100K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Founder Shares
granted
5/17/2017
100KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/17/2017 | Founder Shares granted | 100K | — |
| Total | 100K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
100K
Market value
$6.34M
8/19/2026
Total
Units
100K
Value
$6.34M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/19/2026 | 100K | $6.34M | Nasdaq | Planned |
| Total | 100K | $6.34M | ||